ஐரோப்பிய சிறுநீரகம் கவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஐரோப்பிய சிறுநீரகம் கவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஐரோப்பிய சிறுநீரகம் கவனம் Today - Breaking & Trending Today

Did Don Draper Have More Testosterone Than Men Today? - The Good Men Project

The Good Men Project
Become a Premium Member
We have pioneered the largest worldwide conversation about what it means to be a good man in the 21st century.
Your support of our work is inspiring and invaluable.
Did Don Draper Have More Testosterone Than Men Today?
How exposure to chemical toxins is changing our bodies.
I admit it. I love
Mad Men, the series Matthew Weiner created and that ran on AMC from 2007 to 2015. Watching Don Draper, Roger Sterling, Joan Harris, Peggy Olsen, and the rest of the characters, whose lives are wrapped up in the mid-1960s ad firm Sterling Cooper, is like riding in a tour vehicle among the dinosaurs of ....

New York , United States , Hoosick Falls , Matthew Weiner , Joseph Braun , James Flynn , Joan Harris , Don Draper , Joseph Biden , Hui Zheng , Debbie Dingell , Peggy Olsen , Department Of Epidemiology At Brown University , Ohio State University , Environmental Working Group , Healthyliving Foundation , American Psychological Association , Mad Men , Roger Sterling , Sterling Cooper , Cretaceous Period , Madison Avenue , Management Science , Good Men Project , Biological Psychology , Massachusetts Male Aging Study ,

LIDDS AB: European Urology Focus has accepted a scientific article describing LIDDS Phase IIb study results with Liproca Depot

(1)
UPPSALA, SWEDEN - LIDDS AB (publ) announces that a scientific article will be published in the highly ranked European Urology Focus describing LIDDS clinical Phase IIb study, LPC-004, and its clinical results. The study met both primary and secondary endpoints by confirming efficacy and safety with Liproca Depot given as intraprostatic injection in low- and intermediate risk prostate cancer patients.
We are pleased that this manuscript is accepted in a highly recognized scientific paper and the results further validates NanoZolid as being an innovative technology platform, said Monica Wallter, CEO of LIDDS.
Liproca Depot, which comprises the NanoZolid technology combined with an antiandrogen drug (2-hydroxyflutamide) injected into the prostate, met both the primary and secondary endpoints in the study. Efficacy was shown by a maintained PSA decrease over 6 months, lower prostate volume and unchanged or improved MRI results. No hormonal side effects were shown. L ....

Uppsala Lan , Laurence Klotz , Monica Wallter , University Of Toronto Division Urology , European Urology Focus , Liproca Depot , Professor Laurence Klotz , Toronto Division , லாரன்ஸ் கிலோட்ஜ , பல்கலைக்கழகம் ஆஃப் டொராண்டோ பிரிவு சிறுநீரகம் , ஐரோப்பிய சிறுநீரகம் கவனம் , ப்ரொஃபெஸர் லாரன்ஸ் கிலோட்ஜ , டொராண்டோ பிரிவு ,

Investegate |LIDDS AB Announcements | LIDDS AB: European Urology Focus has accepted a scientific article describing LIDDS Phase IIb study results with Liproca® Depot

LIDDS AB
European Urology Focus has accepted a scientific article describing LIDDS Phase IIb study results with Liproca® Depot
European Urology Focus has accepted a scientific article describing LIDDS Phase IIb study results with Liproca® Depot
UPPSALA, SWEDEN – LIDDS AB (publ) announces that a scientific article will be published in the highly ranked European Urology Focus describing LIDDS clinical Phase IIb study, LPC-004, and its clinical results. The study met both primary and secondary endpoints by confirming efficacy and safety with Liproca Depot given as intraprostatic injection in low- and intermediate risk prostate cancer patients.
“We are pleased that this manuscript is accepted in a highly recognized scientific paper and the results further validates NanoZolid® as being an innovative technology platform,” said Monica Wallter, CEO of LIDDS. ....

Uppsala Lan , Laurence Klotz , Monica Wallter , University Of Toronto Division Urology , European Urology Focus , Liproca Depot , Professor Laurence Klotz , Toronto Division , Nasdaq First North , Certified Adviser , லாரன்ஸ் கிலோட்ஜ , பல்கலைக்கழகம் ஆஃப் டொராண்டோ பிரிவு சிறுநீரகம் , ஐரோப்பிய சிறுநீரகம் கவனம் , ப்ரொஃபெஸர் லாரன்ஸ் கிலோட்ஜ , டொராண்டோ பிரிவு , நாஸ்டாக் முதல் வடக்கு ,